RT Journal
T1 Error in wording in: Persistence of cardiovascular risk after rofecoxib discontinuation
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2011
FD February 28
VO 171
IS 4
SP 305
OP 305
DO 10.1001/archinternmed.2010.546
UL http://dx.doi.org/10.1001/archinternmed.2010.546
AB 
Error in Wording. In the Research Letter titled “Persistence of Cardiovascular Risk After Rofecoxib Discontinuation” by Ross et al, published in the December 13/27 issue of the Archives (2010;170[22]:2035-2036), an error occurred in the “Results” section on page 2035, where the last sentence should have read “Overall, an investigator-reported cardiovascular thromboembolic adverse event or death occurred during off-drug follow-up for 45 subjects, 32 in 287 patient-years among rofecoxib users and 13 in 234 patient-years among placebo users (RR, 2.01; 95% CI, 1.05-3.82; P = .03) (Figure).”